| High-precision plasma β-amyloid 42/40 predicts current and future brain amyloidosis SE Schindler, JG Bollinger, V Ovod, KG Mawuenyega, Y Li, BA Gordon, ... Neurology 93 (17), e1647-e1659, 2019 | 641 | 2019 |
| Cholesterol-dependent γ-secretase activity in buoyant cholesterol-rich membrane microdomains S Wahrle, P Das, AC Nyborg, C McLendon, M Shoji, T Kawarabayashi, ... Neurobiology of disease 9 (1), 11-23, 2002 | 544 | 2002 |
| ABCA1 is required for normal central nervous system ApoE levels and for lipidation of astrocyte-secreted apoE SE Wahrle, H Jiang, M Parsadanian, J Legleiter, X Han, JD Fryer, ... Journal of Biological Chemistry 279 (39), 40987-40993, 2004 | 527 | 2004 |
| Overexpression of ABCA1 reduces amyloid deposition in the PDAPP mouse model of Alzheimer disease SE Wahrle, H Jiang, M Parsadanian, J Kim, A Li, A Knoten, S Jain, ... The Journal of clinical investigation 118 (2), 671-682, 2008 | 439 | 2008 |
| Deletion of Abca1 increases Aβ deposition in the PDAPP transgenic mouse model of Alzheimer disease SE Wahrle, H Jiang, M Parsadanian, RE Hartman, KR Bales, SM Paul, ... Journal of Biological Chemistry 280 (52), 43236-43242, 2005 | 387 | 2005 |
| Assessment of racial disparities in biomarkers for Alzheimer disease JC Morris, SE Schindler, LM McCue, KL Moulder, TLS Benzinger, ... JAMA neurology 76 (3), 264-273, 2019 | 258 | 2019 |
| Cerebrospinal fluid biomarkers measured by Elecsys assays compared to amyloid imaging SE Schindler, JD Gray, BA Gordon, C Xiong, R Batrla-Utermann, M Quan, ... Alzheimer's & Dementia 14 (11), 1460-1469, 2018 | 220 | 2018 |
| Appropriate use criteria for lumbar puncture and cerebrospinal fluid testing in the diagnosis of Alzheimer's disease LM Shaw, J Arias, K Blennow, D Galasko, JL Molinuevo, S Salloway, ... Alzheimer's & Dementia 14 (11), 1505-1521, 2018 | 190 | 2018 |
| Apolipoprotein E and low density lipoprotein receptor-related protein facilitate intraneuronal Aβ42 accumulation in amyloid model mice CV Zerbinatti, SE Wahrle, H Kim, JA Cam, K Bales, SM Paul, ... Journal of Biological Chemistry 281 (47), 36180-36186, 2006 | 149 | 2006 |
| Production and characterization of astrocyte-derived human apolipoprotein E isoforms from immortalized astrocytes and their interactions with amyloid-β M Morikawa, JD Fryer, PM Sullivan, EA Christopher, SE Wahrle, ... Neurobiology of disease 19 (1-2), 66-76, 2005 | 139 | 2005 |
| Validation of plasma amyloid-β 42/40 for detecting Alzheimer disease amyloid plaques Y Li, SE Schindler, JG Bollinger, V Ovod, KG Mawuenyega, MW Weiner, ... Neurology 98 (7), e688-e699, 2022 | 112 | 2022 |
| Apolipoprotein E levels in cerebrospinal fluid and the effects of ABCA1polymorphisms SE Wahrle, AR Shah, AM Fagan, S Smemo, JSK Kauwe, A Grupe, ... Molecular neurodegeneration 2, 1-9, 2007 | 97 | 2007 |
| Anti-tau antibody administration increases plasma tau in transgenic mice and patients with tauopathy K Yanamandra, TK Patel, H Jiang, S Schindler, JD Ulrich, AL Boxer, ... Science translational medicine 9 (386), eaal2029, 2017 | 90 | 2017 |
| Photo-activatable Cre recombinase regulates gene expression in vivo SE Schindler, JG McCall, P Yan, KL Hyrc, M Li, CL Tucker, JM Lee, ... Scientific reports 5 (1), 13627, 2015 | 90 | 2015 |
| Emerging cerebrospinal fluid biomarkers in autosomal dominant Alzheimer's disease SE Schindler, Y Li, KW Todd, EM Herries, RL Henson, JD Gray, G Wang, ... Alzheimer's & Dementia 15 (5), 655-665, 2019 | 87 | 2019 |
| ATN profiles among cognitively normal individuals and longitudinal cognitive outcomes A Soldan, C Pettigrew, AM Fagan, SE Schindler, A Moghekar, C Fowler, ... Neurology 92 (14), e1567-e1579, 2019 | 84 | 2019 |
| Neuropsychological measures that detect early impairment and decline in preclinical Alzheimer disease SE Schindler, MS Jasielec, H Weng, JJ Hassenstab, E Grober, LM McCue, ... Neurobiology of aging 56, 25-32, 2017 | 80 | 2017 |
| Addressing health disparities among minority populations: why clinical trial recruitment is not enough CH Wilkins, SE Schindler, JC Morris JAMA neurology 77 (9), 1063-1064, 2020 | 74 | 2020 |
| Chemotherapy-associated posterior reversible encephalopathy syndrome: a case report and review of the literature J How, M Blattner, S Fowler, A Wang-Gillam, SE Schindler The neurologist 21 (6), 112-117, 2016 | 70 | 2016 |
| Effect of race on prediction of brain amyloidosis by plasma Aβ42/Aβ40, phosphorylated tau, and neurofilament light SE Schindler, TK Karikari, NJ Ashton, RL Henson, KE Yarasheski, T West, ... Neurology 99 (3), e245-e257, 2022 | 67 | 2022 |
Tammie L.S. Benzinger, MD, PhDDepartments of Radiology and Neurosurgery, Washington University School of Medicine in Saint LouisVerified email at wustl.edu
